Evaxion A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Q: What does CUSIP 29970R303 represent in this 13F holders report?

CUSIP 29970R303 is the security identifier for EVAX - Evaxion A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share used to aggregate holder disclosures.

Q: How many institutions held EVAX - Evaxion A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share in Q2 2026?

5 institutional investors reported EVAX - Evaxion A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 29970R303

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
Total 13F shares: 83,293
Total 13F value: $258,229
Share change: +20,044
SEC-reported price per share: $3.10
Number of holders: 5
Value change: +$60,752
Number of buys: 1
Number of sells: 2
Shares outstanding: 6,399,690

Security key

29970R303

Report period

Q2 2026

Institutions

Top holders

EVAX full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Evaxion A/S SEC filings Evaxion A/S company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 29970R303

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of EVAX - Evaxion A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Merck & Co., Inc.

Disclosed value leader

Merck & Co., Inc.

Comparable rows

15/15

Latest evidence

16 Apr 2026

13D/G 13F 3/4/5 Lead comparable stake: 20% 13D/G row: Merck & Co., Inc. Showing 1-6 of 15 holder rows.

Quick read

Merck & Co., Inc. leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Merck & Co., Inc.'s linked filing trail.

Comparable ownership Top 5

Merck & Co., Inc. 20%

ARMISTICE CAPITAL, LLC 5%

Andreas Holm Mattsson 1.8%

Marianne Soegaard 1.2%

Katrina Tayton Martin 0.72%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Merck & Co., Inc.	13D/G 13F Company 13D/G 13F	20%	$105,531,938 63,004,142 shares	$0	31 Jan 2025
ARMISTICE CAPITAL, LLC	13D/G 13D/G	5%	$506,019 310,441 shares	-$536,087	31 Mar 2025
Andreas Holm Mattsson	3/4/5 CAIO Chief AI Officer 3/4/5	1.8%	$26,353,849 5,524,916 shares	—	18 Mar 2026
Marianne Soegaard	3/4/5 Director 3/4/5	1.2%	$18,427,056 3,863,115 shares	—	18 Mar 2026
Katrina Tayton Martin	3/4/5 Chief Executive Officer 3/4/5	0.72%	$10,904,935 2,286,150 shares	—	18 Mar 2026
Roberto Prego	3/4/5 Director 3/4/5	0.37%	$5,585,812 1,171,030 shares	—	18 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

83,293

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

-10

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend